Szot Matthew K
SenesTech, Inc. · Director
Szot Matthew K is listed in filings as Director at SenesTech, Inc.. This profile follows SEC Form 4 activity through Dec 31, 2025, including sale activity. Recent filings connect the profile to SenesTech, Inc. (SNES) and Cadrenal Therapeutics, Inc. Common Stock (CVKD). The current snapshot covers public activity from Aug 28, 2024 to Dec 31, 2025. Reported amounts are shown as $34.0K to $989.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.